Absorica LD was approved by USFDA on 5 Nov. 2019.
In contrast to Absorica, Absorica LD contains Micronized Isotretinoin in suspension filled in hard gelatin capsules.
Absorica is not substitutable with Absorica LD because of different bioavailability and recommended dosage. Absorica LD may have enhanced bioavailability in comparison to Absorica.
Comparison between Absorica and Absorica LD is available below
In contrast to Absorica, Absorica LD contains Micronized Isotretinoin in suspension filled in hard gelatin capsules.
Absorica is not substitutable with Absorica LD because of different bioavailability and recommended dosage. Absorica LD may have enhanced bioavailability in comparison to Absorica.
Comparison between Absorica and Absorica LD is available below
No comments:
Post a Comment